An official website of the United States government
Home
Name
Relacatib
Alternate Names
GSK 462795
GSK-462795
GSK462795
Abbreviations
None
Category
Chemotherapy
Subcategory
Cytostatic agent--cathepsin-K inhibitor
NSC Number
None
Primary Site
Bone metastases
Histology
None
Remarks
Phase II GlaxoSmithKline.
Coding
This drug should be coded
